Japanese Encephalitis, a disease which has a fatality rate of over 25%, is becoming one of the leading causes of death and disability through viral neurological infection in the country, an investigation by the IEDCR has found.
In a study done in 48 districts, around 7% of the surveyed patients were found to be infected with Japanese Encephalitis, according to the “Acute Meningo-Encephalitis Surveillance Bangladesh (2007-2013)” report published by the Institute of Epidemiology, Disease Control and Research (IEDCR) at the institute’s auditorium yesterday.
Dr Mahmudur Rahman, director of the IEDCR, told reporters that the disease has been emerging as a new public health concern for Bangladesh. The fatality rate of Japanese Encephalitis was around 25-30%, he said, adding that there was no specific treatment for a cure.
Urging the government to address the health concern immediately, the IEDCR chief said more research, discussion among policymakers, introduction of vaccines, inter-country discussion, and formulation of a plan to control Japanese Encephalitis was needed to tackle the crisis.
Serum samples from 4,408 patients at four medical college hospitals – Rajshahi, Khulna, Chittagong and Rangpur – were collected and analysed for diagnosing Japanese Encephalitis and Nipah diseases, and making bacterial identification.
Among the surveyed cases, 294 patients were diagnosed with Japanese Encephalitis; 148 in Rajshahi, 110 in Rangpur, 19 in Khulna and 17 at Chittagong Medical College Hospital.
Ruksana Kader, additional secretary of the Health Ministry, also urged journalists to publish more reports on the disease to create more awareness. Among others, Dr Shah Newaz, director (administration) of the health directorate, was present at the programme.
The mosquito-borne Japanese Encephalitis virus is mostly asymptomatic or result in only mild symptoms. However, some of those infected eventually develop encephalitis (inflammation of the brain), with symptoms including headache, fever, convulsions, tremors, disorientation and coma.



